Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
Research from University Hospital provides new data on HIV/AIDS
March 25th, 2009
According to a study from Bern, Switzerland, "Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency virus (HIV)-infected patients, and adequate immunogenicity and safety are of concern in this population. In the Swiss HIV Cohort Study, we identified 102 patients who received 17DV while they were HIV infected." "We analyzed neutralization titers (NTs) after 17DV administration using the plaque reduction neutralization test. NTs of 1: >= 10 were defined as reactive, and those of 1: >= 10 were defined as nonreactive, which was considered to be nonprotective. The results were compared with data for HIV-uninfected individuals. Serious...
Source: Vaccine Weekly (2009-03-25)
|
